Last Thursday, fans were shocked when Demna, from Georgia, was named as Gucci's new artistic director, officially due to take over the role in July.

according to data—and see the rest of the 50 highest-rated cities Ukrainian government sells T-shirts with viral Zelensky quote from disastrous Trump meeting Inflammation on Your Plate ...

Workers standing about 15 feet to his right then revealed T-shirts that when they stood side-by-side spelled out the question “Does Our Code Kill Kids, Satya?” Photos and video of the incident ...

Moderna CEO Stéphane Bancel received an annual compensation package worth $19.87 million last year, the largest he’s ever received at the company. The 16.4% increase—at grant value—came ...

Moderna recently experienced a notable 10% price increase over the last week amidst significant legal and financial developments. Genevant Sciences and Arbutus Biopharma have expanded their patent ...

HHS cites need for review due to 'oversight' issues CDC states low risk of H5 bird flu to public Moderna's shares drop 5.5% Feb 26 (Reuters) - U.S. health officials are reevaluating a $590 million ...

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to Moderna Inc., people familiar with the matter said. The review is part of a ...

Investors with a lot of money to spend have taken a bullish stance on Moderna MRNA. And retail traders should know. We noticed this today when the trades showed up on publicly available options ...

Moderna Inc.’s stock erased early losses to gain more than 3% on Friday, after the biotech company posted a wider-than-expected fourth-quarter loss and offered soft guidance for 2025, offsetting ...

(Bloomberg) -- US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to Moderna Inc., people familiar with the matter said.

Friday marked the worst day of the year for the stock market as the Dow lost 748.63 points, however, pharmaceutical companies stood out as a glaring exception, with both Pfizer and Moderna stocks ...